BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1549 related articles for article (PubMed ID: 16862118)

  • 21. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.
    Wei J; Wunderlich M; Fox C; Alvarez S; Cigudosa JC; Wilhelm JS; Zheng Y; Cancelas JA; Gu Y; Jansen M; Dimartino JF; Mulloy JC
    Cancer Cell; 2008 Jun; 13(6):483-95. PubMed ID: 18538732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal and leukaemic stem cells.
    Bonnet D
    Br J Haematol; 2005 Aug; 130(4):469-79. PubMed ID: 16098060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
    Rizo A; Vellenga E; de Haan G; Schuringa JJ
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R210-9. PubMed ID: 16987886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
    Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
    Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
    Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
    Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
    Cano F; Drynan LF; Pannell R; Rabbitts TH
    Oncogene; 2008 Mar; 27(13):1945-50. PubMed ID: 17906700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.
    Schwieger M; Schüler A; Forster M; Engelmann A; Arnold MA; Delwel R; Valk PJ; Löhler J; Slany RK; Olson EN; Stocking C
    Blood; 2009 Sep; 114(12):2476-88. PubMed ID: 19584403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the initiation and progression of human acute leukemia in mice.
    Barabé F; Kennedy JA; Hope KJ; Dick JE
    Science; 2007 Apr; 316(5824):600-4. PubMed ID: 17463288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.
    Chen W; Kumar AR; Hudson WA; Li Q; Wu B; Staggs RA; Lund EA; Sam TN; Kersey JH
    Cancer Cell; 2008 May; 13(5):432-40. PubMed ID: 18455126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
    Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
    Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic myeloid leukemia: proving ground for cancer stem cells.
    Daley GQ
    Cell; 2004 Oct; 119(3):314-6. PubMed ID: 15507204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for cancer stem cells in human endometrial carcinoma.
    Hubbard SA; Friel AM; Kumar B; Zhang L; Rueda BR; Gargett CE
    Cancer Res; 2009 Nov; 69(21):8241-8. PubMed ID: 19843861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Searching for leukemia stem cells--not yet the end of the road?
    Jordan CT
    Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concepts of human leukemic development.
    Warner JK; Wang JC; Hope KJ; Jin L; Dick JE
    Oncogene; 2004 Sep; 23(43):7164-77. PubMed ID: 15378077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.